跳至主要内容
临床试验/NCT04282434
NCT04282434已完成不适用

CLinical Epigenetic-sensitive trajectOries Underlying Pulmonary Arterial Hypertension and neTwoRk Analysis (CLEOPAHTRA)

University of Campania "Luigi Vanvitelli"1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年6月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Identification of differentially methylated regions in CD04 and CD08 T cells

研究概览

简要总结

To identify epigenetic-sensitive modifications and novel biomarkers linked to pathogenesis of pulmonary arterial hypertension (PAH), we will perform the first study analyzing differentially-methylated regions (DMRs) in circulating T cells (CD04+ and CD08+) isolated from peripheral blood of patients undergoing right heart catheterization. Moreover, we will perform RNA deep sequencing on lung tissue biopsies to validate if DNA methylation signatures in circulating T cells could reflect perturbations of gene expression in lung tissues.

详细描述

Pulmonary arterial hypertension (PAH) is characterized by remodeling of pulmonary arteries caused by an inbalance of proliferation/apoptosis rate within the vascular wall. This pathological phenotype seems to be triggered by different environmental stress and injury events such as increased inflammation, DNA damage, and epigenetic deregulation. Many immune cells are increased in PAH, such as T and B lymphocytes. Remarkably, T cells are essential players of adaptive immunity and may be relevant initiators ("initial hit") of vascular remodelling. We will perform the first multi-omics study to: 1) investigate DNA methylome of circulating T cells isolated from peripheral blood of PAH patients, 2) detect transcriptomic profiles of lung tissues, 3) to assess if DNA methylation of distinct genomic regions in circulating T cells could reflect modifications of lung gene expression programs.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Newly diagnosed patients with World Health Organization (WHO) Group I PAH.
  • ≥ 18 years
  • Documentation of the following hemodynamic parameters by right heart catheterization, performed at time of study enrolment:
  • Mean pulmonary arterial pressure (mPAP) > 25 mmHg at rest or mPAP > 30 mm Hg with exercise.
  • Pulmonary arterial wedge pressure (PAWP) ≤ 15 mm Hg.
  • Pulmonary vascular resistance (PVR) ≥ 240 dynes.sec.cm-5 (e.g., ≥ 3.0 Wood units)

排除标准

  • Patients who meet the criteria for inclusion into WHO Groups II, III, IV or V.
  • Do not meet the required hemodynamic criteria for entry into the study.
  • Patients with known history of cancer, malignancy disorders, active infections, and chronic or immune-mediated diseases.

结局指标

主要结局

Identification of differentially methylated regions in CD04 and CD08 T cells

时间窗: 3 Months

Reduced Representation Bisulfite Sequencing

Identification of differentially expressed genes in lung tissue biopsies

时间窗: 5 Months

Chip Microarray

Bioinformatic analysis

时间窗: 8 Months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Giuditta Benincasa

Principal Investigator Giuditta Benincasa

University of Campania "Luigi Vanvitelli"

研究点 (1)

Loading locations...

相似试验